Dysphagia in head and neck cancer patients following intensity modulated radiotherapy (IMRT)

Radiation Oncology

Volumn 6, Issue 1, 2011, Pages

  Peponi, Evangelia ^a   Glanzmann, Christoph ^a   Willi, Bettina ^b   Huber, Gerhard ^a   Studer, Gabriela ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b Hospital of Lugano   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; COHORT ANALYSIS; DYSPHAGIA; FEMALE; FOLLOW UP; HUMAN; HYPOPHARYNX CARCINOMA; INTENSITY MODULATED RADIATION THERAPY; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; OROPHARYNX CARCINOMA; PATIENT ASSESSMENT; RADIATION DOSE DISTRIBUTION; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; TUMOR VOLUME; ADULT; AGED; DISEASE FREE SURVIVAL; EVALUATION; HEAD AND NECK TUMOR; MIDDLE AGED; MORTALITY; RADIATION DOSE; RADIATION INJURY; SURVIVAL; TIME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DEGLUTITION DISORDERS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 78650800067     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-6-1     Document Type: Article

References (26)

1. Studer G, Huguenin PU, Davis JB, Kunz G, Lutolf UM, Glanzmann C. IMRT using simultaneously integrated boost (SIB) in head and neck cancer patients. Radiat Oncol 2006, 1:7. 10.1186/1748-717X-1-7, 1459185, 16722599.
2. Feng Y, Kim HM, et al. Intensity-Modulated Chemoradiotherapy Aiming to Reduce Dysphagia in Patients With Oropharyngeal Cancer: Clinical and Functional Results. J Clin Oncol 2010, 28:2732-2738. 10.1200/JCO.2009.24.6199, 20421546.
3. Caudell JJ, Schaner PE, Meredith RF, et al. Factors Associated With Long-Term Dysphagia After Definitive Radiotherapy for Locally Advanced Head-and-Neck Cancer. International Journal of Radiation Oncology, Biology, Physics 2009, 73:410-415.
4. Cooper J, Fleming ID, HD. editors Head and Neck Cancer. AJCC Manual for Staging of Cancer 2002, Philadelphia: JB Lippincott, 6, editors.
5. James DC, JoAnn S, Thomas FP. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC). International journal of radiation oncology, biology, physics 1995, 31:1341-1346. 10.1016/0360-3016(95)00060-C, 7713792.
6. Eisbruch A, Schwartz M, Rasch C, et al. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: Which anatomic structures are affected and can they be spared by IMRT?. International Journal of Radiation Oncology Biology Physics 2004, 60:1425-1439.
7. Levendag PC, Teguh DN, Voet P, et al. Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: A dose-effect relationship. Radiotherapy and Oncology 2007, 85:64-73. 10.1016/j.radonc.2007.07.009, 17714815.
8. Sanguineti G, Adapala P, Endres EJ, et al. Dosimetric Predictors of Laryngeal Edema. International Journal of Radiation Oncology Biology Physics 2007, 68:741-749.
9. Caglar HB, Tishler RB, Othus M, et al. Dose to Larynx Predicts for Swallowing Complications After Intensity-Modulated Radiotherapy. International Journal of Radiation Oncology Biology Physics 2008, 72:1110-1118.
10. Fang F-M, Chien C-Y, Tsai W-L, et al. Quality of Life and Survival Outcome for Patients With Nasopharyngeal Carcinoma Receiving Three-Dimensional Conformal Radiotherapy vs. Intensity-Modulated Radiotherapy--A Longitudinal Study. International Journal of Radiation Oncology Biology Physics 2008, 72:356-364.
11. Fu KK, Pajak TF, Trotti A, et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 2000, 48:7-16. 10.1016/S0360-3016(00)00663-5, 10924966.
12. Forastiere AA, Goepfert H, Maor M, et al. Concurrent Chemotherapy and Radiotherapy for Organ Preservation in Advanced Laryngeal Cancer. N Engl J Med 2003, 349:2091-2098. 10.1056/NEJMoa031317, 14645636.
13. Eisbruch A, Lyden T, Bradford CR, et al. Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer. International Journal of Radiation Oncology Biology Physics 2002, 53:23-28.
14. de Arruda FF, Puri DR, Zhung J, et al. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience. Int J Radiat Oncol Biol Phys 2006, 64:363-373. 10.1016/j.ijrobp.2005.03.006, 15925451.
15. Teguh DN, Levendag PC, Noever I, et al. Treatment techniques and site considerations regarding dysphagia-related quality of life in cancer of the oropharynx and nasopharynx. Int J Radiat Oncol Biol Phys 2008, 72:1119-1127. 10.1016/j.ijrobp.2008.02.061, 18472364.
16. Dirix P, Nuyts S. Value of Intensity-Modulated Radiotherapy in Stage IV Head-and-neck Squamous Cell Carcinoma. International Journal of Radiation Oncology, Biology, Physics 2010, 78:1373-1380.
17. Lee NY, de Arruda FF, Puri DR, et al. A comparison of intensity-modulated radiation therapy and concomitant boost radiotherapy in the setting of concurrent chemotherapy for locally advanced oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2006, 66:966-974. 10.1016/j.ijrobp.2006.06.040, 17145527.
18. Fua TF, Corry J, Milner AD, Cramb J, Walsham SF, Peters LJ. Intensity-modulated radiotherapy for nasopharyngeal carcinoma: Clinical correlation of dose to the pharyngo-esophageal axis and dysphagia. International Journal of Radiation Oncology, Biology, Physics 2007, 67:976-981.
19. Huguenin P, Beer KT, Allal A, et al. Concomitant Cisplatin Significantly Improves Locoregional Control in Advanced Head and Neck Cancers Treated With Hyperfractionated Radiotherapy. J Clin Oncol 2004, 22:4665-4673. 10.1200/JCO.2004.12.193, 15534360.
20. Caudell JJ, Schaner PE, Desmond RA, Meredith RF, Spencer SA, Bonner JA. Dosimetric Factors Associated With Long-Term Dysphagia After Definitive Radiotherapy for Squamous Cell Carcinoma of the Head and Neck. International Journal of Radiation Oncology, Biology, Physics 2010, 76:403-409.
21. Feng FY, Kim HM, Lyden TH, et al. Intensity-Modulated Radiotherapy of Head and Neck Cancer Aiming to Reduce Dysphagia: Early Dose-Effect Relationships for the Swallowing Structures. International Journal of Radiation Oncology Biology Physics 2007, 68:1289-1298.
22. Studer G, Peponi E, Kloeck S, Dossenbach T, Huber G, Glanzmann C. Surviving Hypopharynx-Larynx Carcinoma in the Era of IMRT. International Journal of Radiation Oncology, Biology, Physics 2010, 77:1391-1396.
23. Langendijk JA, Doornaert P, Rietveld DHF, Verdonck-de Leeuw IM, René Leemans C, Slotman BJ. A predictive model for swallowing dysfunction after curative radiotherapy in head and neck cancer. Radiotherapy and Oncology 2009, 90:189-195. 10.1016/j.radonc.2008.12.017, 19167120.
24. Joke W, Kim De R, Duprez F, et al. Acute Normal Tissue Reactions in Head-and-Neck Cancer Patients Treated With IMRT: Influence of Dose and Association With Genetic Polymorphisms in DNA DSB Repair Genes. International journal of radiation oncology, biology, physics 2009, 73:1187-1195. 10.1016/j.ijrobp.2008.08.073, 19251090.
25. Chao KSC, Gokhan O, Wade LT. Toxicity profile of intensity-modulated radiation therapy for head and neck carcinoma and potential role of amifostine. Seminars in oncology 2003, 30:101-108.
26. Denis F, Garaud P, Bardet E, et al. Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: comparison of LENT/SOMA, RTOG/EORTC, and NCI-CTC scoring systems. International Journal of Radiation Oncology Biology Physics 2003, 55:93-98.